Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study
|
|
- Jemima Lang
- 5 years ago
- Views:
Transcription
1 Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study Joseph A. Vita, MD; John F. Keaney, Jr, MD; Martin G. Larson, ScD; Michelle J. Keyes, MA; Joseph M. Massaro, PhD; Izabella Lipinska, PhD; Birgitta T. Lehman, RDCS; Shuxia Fan, RN; Ewa Osypiuk, MD; Peter W.F. Wilson, MD; Ramachandran S. Vasan, MD; Gary F. Mitchell, MD; Emelia J. Benjamin, MD, ScM Background In experimental studies, traditional risk factors and proinflammatory processes alter the regulatory functions of the vascular endothelium to promote atherosclerosis. These alterations include expression of leukocyte adhesion molecules and decreased bioavailability of endothelium-derived nitric oxide, an important regulator of vascular homeostasis and tone. The precise relations among risk factors, inflammation, and nitric oxide bioavailability remain uncertain. Methods and Results To test the hypothesis that inflammation impairs endothelial function in humans, we measured brachial artery flow-mediated dilation, reactive hyperemia, and serum concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), soluble intracellular adhesion molecule-1 (sicam-1), and monocyte chemotactic protein-1 (MCP-1) in 2701 participants from the Framingham Study (mean age 61 years, 53% women). There were modest unadjusted inverse correlations between flow-mediated dilation and CRP, IL-6, and sicam-1 (P for all) that were rendered nonsignificant after accounting for traditional coronary risk factors. For reactive hyperemia, we observed inverse correlations with markers of inflammation in unadjusted models that were attenuated 57% to 74% after accounting for risk factors. However, partial correlations of CRP, IL-6, and sicam-1 with reactive hyperemia remained significant. Conclusions Our observations are consistent with the hypothesis that risk factors induce a state of inflammation that impairs vascular function. For flow-mediated dilation, we found no evidence that inflammation has additional effects beyond those attributable to traditional risk factors. The incremental contribution of CRP, IL-6, and sicam-1 to reactive hyperemia above and beyond known risk factors suggests that systemic inflammation may contribute to impaired vasomotor function in forearm microvessels. (Circulation. 2004;110: ) Key Words: endothelium inflammation atherosclerosis risk factors cardiovascular diseases The inflammatory nature of atherosclerosis is now well accepted. 1 3 During atherogenesis, recruitment of leukocytes to the arterial wall promotes the development of atherosclerotic lesions. Later in the disease, inflammation promotes plaque rupture and acute coronary syndromes. In support of these concepts, serum markers of inflammation, including C-reactive protein (CRP), interleukin-6 (IL-6), the soluble form of intercellular adhesion molecule-1 (sicam-1), and monocyte chemotactic protein-1 (MCP-1), predict cardiovascular disease events. 3 The vascular endothelium contributes to inflammatory responses in atherosclerosis. 1,2,4 Experimental studies indicate that certain cardiovascular risk factors and proinflammatory cytokines activate endothelial cells to express leukocyte adhesion molecules, which promotes adhesion of monocytes and T lymphocytes to the endothelial surface. Endothelial cells and other vascular cells also produce MCP-1 and other chemoattractants that promote leukocyte accumulation in the vascular wall. The presence of cardiovascular disease risk factors, cytokines, and inflammatory factors such as CRP induces important phenotypic changes in the endothelium, including a decrease in the production and/or biological activity of endothelium-derived nitric oxide. 4,5 Decreased nitric oxide activity promotes leukocyte adhesion, thrombosis, vasoconstriction, and cellular proliferation and thus plays a role in all stages of atherosclerosis. 6 Previous human studies examining the relation between endothelial function and specific markers of inflammation Received March 29, 2004; revision received July 10, 2004; accepted September 7, From the Evans Memorial Department of Medicine (J.A.V., J.F.K., R.S.V., E.J.B.), Whitaker Cardiovascular Institute (J.A.V., J.F.K., I.L.), and Department of Preventive Medicine (M.G.L., R.S.V., E.J.B.), Boston University School of Medicine, Boston, Mass; Cardiovascular Engineering, Inc (G.F.M.), Holliston, Mass; and the NHLBI s Framingham Study (M.G.L., M.J.K., J.M.M., B.T.L., S.F., E.O., P.W.F.W., R.S.V., E.J.B.), Framingham, Mass. Consulting Editor for this article was Meir J. Stampfer, MD. Correspondence to Joseph A. Vita, MD, Boston Medical Center, 88 E Newton St, C-818, Boston, MA jvita@bu.edu 2004 American Heart Association, Inc. Circulation is available at DOI: /01.CIR E 3604
2 Vita et al Inflammation and Endothelial Function 3605 have yielded inconsistent results, although much of that work involved relatively small numbers of highly selected individuals. 7 9 The present study examined the cross-sectional relations between vasodilator function in the forearm (brachial artery flow-mediated dilation and reactive hyperemia) and 4 systemic markers of inflammation (CRP, IL-6, sicam-1, and MCP-1), while adjusting for known risk factors in a large, community-based sample. Methods Participants The design for the Framingham Offspring Study has been described elsewhere. 10 Participants in the seventh examination cycle (1998 to 2001) were eligible for the present investigation (n 3539). Participants were excluded for the following reasons: nursing home examination (n 205), missing covariate data (n 12), missing inflammatory marker data (n 170), and the unavailability of 2D ultrasound data as described previously 11 (n 451), which left a total of 2701 individuals for investigation of flow-mediated dilation. For investigation of the relation between reactive hyperemia and markers of inflammation, we limited the analysis to the 1903 participants with Doppler flow data. All participants underwent routine medical history, physical examination, and laboratory assessment. Individuals were instructed not to eat or drink anything except water or decaffeinated black coffee or tea after 8 PM the previous evening. Cigarette smoking was determined by self-report. Heart rate and blood pressure were measured by an automatic device (Dinamap, model No. 1846SX, Critikon, Inc). Diabetes was defined as fasting glucose 126 mg/dl or use of hypoglycemic medication. Prior cardiovascular disease (coronary heart disease, stroke, intermittent claudication, or congestive heart failure) was documented as described previously. 12 The examination included a 6-minute exercise test (Bruce protocol stages I and II) in participants without contraindications (known coronary heart disease, chest pain on test day, or inability to perform test). The Boston Medical Center Institutional Review Board approved the study, and all participants provided written informed consent. Determination of Flow-Mediated Dilation and Reactive Hyperemia The method and reproducibility for determining flow-mediated dilation have been described previously. 11 Briefly, a Toshiba #SSH- 140A ultrasound system with 7.5-MHz linear array transducer (Toshiba Medical) was used to record 2D images of the brachial artery at baseline and 1 minute after induction of reactive hyperemia by 5-minute cuff occlusion of the forearm. Using a carrier frequency of 3.75 MHz and correction for insonation angle, Doppler flow was assessed at baseline and during peak hyperemic flow, which was visually confirmed to occur within 15 seconds after cuff release. The Doppler flow signals and 2D images were captured digitally with customized equipment (Cardiovascular Engineering, Inc). Personnel blinded to the participant s laboratory and clinical status measured brachial artery diameter at baseline and during reactive hyperemia using commercially available software (Brachial Analyzer, Medical Imaging Applications) as described previously. 11 The coefficients of variation (CVs) for baseline and hyperemia diameters were 0.5% and 0.7%, respectively. Flow-mediated dilation was expressed as actual change in diameter in millimeters (hyperemia diameter at 60 seconds baseline diameter) and as percent change from baseline (100 [hyperemia diameter at 60 seconds baseline diameter]/baseline diameter). 11 Blinded personnel analyzed flow velocity at baseline and during reactive hyperemia using a semiautomated signal-averaging method. 13 As previously reported, repeated analysis of baseline and deflation flow measurements was highly reproducible, with correlations TABLE 1. Clinical Characteristics Characteristic Women (n 1426) Men (n 1275) Age, y Systolic blood pressure, mm Hg Heart rate, bpm Body mass index, kg/m Total cholesterol/hdl ratio Fasting glucose, mg/dl Diabetes, % Smoking past 6 hours, % 9 9 Prevalent cardiovascular disease, % 8 18 Hypertension, % Hormone replacement therapy, % 35 Lipid-lowering medication, % Walk test, % Before brachial testing After brachial testing Values are percentages or mean SD. Serum Markers of Inflammation Serum samples were stored at 70 C. For analysis, samples were thawed at room temperature and subjected to a vigorous vortex, and marker levels were measured in duplicate and averaged with commercially available ELISA kits (R&D Systems) for IL-6, sicam-1, and MCP-1 according to previously described quality-control procedures. 14,15 The median intra-assay CVs were 2.8%, 3.6%, and 3.0%, respectively. CRP was measured with a Dade Behring BN100 nephelometer, and the median CV was 2.2%. Statistical Analysis The distributions of CRP, IL-6, ICAM-1, and MCP-1 were highly skewed, so we used Spearman rank order correlations to assess the association of each marker of inflammation with each measure of flow-mediated dilation and flow. We estimated crude correlations, partial correlations that accounted for gender and age, and partial correlations that accounted for gender, age, and multiple clinical variables using the SAS CORR procedure. 16 A 2-sided probability value 0.05 was considered statistically significant. Results Participant Characteristics and Markers of Inflammation The clinical characteristics of the participants are displayed in Table 1 and are very similar to the characteristics of other subsets of Framingham Offspring participants used in prior studies. 11,14,15 Summary statistics for the measures of vascular function and inflammation are provided in Table 2. Unadjusted correlates among the 4 markers of inflammation are shown in Table 3 and reveal that the inflammatory markers were correlated, particularly CRP and IL-6, which had an unadjusted correlation coefficient of nearly 0.5. Markers of Inflammation and Flow-Mediated Dilation To investigate the hypothesis that systemic inflammation adversely affects conduit artery endothelial function, we examined the correlations between each marker of inflammation and brachial artery flow-mediated dilation (Table 4). We
3 3606 Circulation December 7, 2004 TABLE 2. Markers of Inflammation and Measures of Vascular Function Characteristic Median (Q1 Q3) Values for Women (n 1426) Median (Q1 Q3) Values for Men (n 1275) Markers of inflammation CRP, mg/l 2.5 ( ) 2.0 ( ) IL-6, pg/ml 2.6 ( ) 2.8 ( ) sicam-1, ng/ml 241 ( ) 240 ( ) MCP-1, pg/ml 307 ( ) 319 ( ) Measures of vascular function Baseline brachial diameter, mm 3.7 ( ) 5.0 ( ) Flow-mediated dilation, mm 0.10 ( ) 0.09 ( ) Flow-mediated dilation, % 2.8 ( ) 1.9 ( ) Baseline mean flow, cm/s* 6.2 ( ) 7.1 ( ) Hyperemic mean flow, cm/s* 52.5 ( ) 45.3 ( ) Hyperemic-baseline mean flow ratio* 8.2 ( ) 5.8 ( ) Q1 indicates first quartile; Q3, third quartile. *Flow data are based on 874 men and 1029 women. observed significant inverse correlations between flowmediated dilation and CRP, IL-6, and sicam-1 and a correlation of borderline significance with MCP-1. After adjustment for traditional risk factors, the correlations were no longer statistically significant for CRP (Figure), IL-6, sicam-1, and MCP-1. The multivariable model contained traditional cardiovascular disease risk factors and the other significant multivariable predictors of flow-mediated dilation identified in a previous study and included age, gender, body mass index, systolic blood pressure, total cholesterol:hdl cholesterol ratio, diabetes mellitus, recent cigarette smoking, hormone replacement therapy, lipid-lowering therapy, heart rate, and whether or not the walk test was performed before the study of vascular function. 11 The findings were similar whether flow-mediated dilation was expressed as absolute change or as percent change in diameter. Markers of Inflammation and Brachial Flow Because hyperemic flow is the principal stimulus for flowmediated dilation and an index of microvascular function, 13,17 we investigated the correlations between each marker of inflammation and the extent of reactive hyperemia (Table 4). Reactive hyperemia correlated inversely with CRP, IL-6, sicam-1, and MCP-1 in the unadjusted models. After adjustment for risk factors, the correlations were no longer statistically significant for MCP-1. For CRP, IL-6, and sicam-1, the correlation coefficients were reduced by 57% TABLE 3. Relations Among Levels of Inflammatory Markers Spearman Correlation Coefficients CRP IL-6 ICAM-1 MCP-1 CRP IL sicam n All correlations were significant, P to 74% but remained statistically significant in the multivariable models (Figure). The findings were similar whether the extent of reactive hyperemia was expressed as hyperemic flow or as the ratio of hyperemic flow to baseline flow, as it has often been expressed in prior studies. 17 Given that baseline flow may also be a determinant of endothelial expression of inflammatory factors, 18 we examined the relation between the markers of inflammation and baseline flow. We found modest inverse correlations with CRP, IL-6, and sicam-1 but no relation with MCP-1 in the unadjusted models. After adjustment for age, gender, and other risk factors, we found no significant correlation between baseline flow and any of the markers of inflammation. Possible Effects of Cardiovascular Disease and Cardiovascular Medications Some of the participants had cardiovascular disease or were taking hormone replacement or lipid-lowering therapy (Table 1), and we considered the possibility that these factors might have confounded our results. We therefore repeated the analyses of conduit brachial artery flow-mediated dilation and extent of reactive hyperemia in the subgroups of participants without known cardiovascular disease, not receiving hormone replacement therapy, and not receiving lipidlowering therapy. In each subgroup, the results were not materially different from those for the entire cohort (data not shown). Discussion In our community-based sample, we investigated the relations of markers of inflammation to flow-mediated dilation, a measure of conduit artery vasodilator function, and to reactive hyperemia, a measure of forearm microvascular vasodilator function. We observed modest unadjusted correlations between flow-mediated dilation and the inflammatory markers; however, these relations were rendered nonsignificant on adjustment for cardiovascular disease risk factors. We observed a similar pattern of statistically significant unadjusted correlations and weakened risk factor adjusted correlations between all 4 markers of inflammation and reactive hyperemia. CRP, IL-6, and sicam-1 remained significant correlates of microvascular function after adjustment for cardiovascular risk factors. Investigators have hypothesized that inflammation is an important cause of endothelial dysfunction, 19 but prior human studies relating inflammation to endothelium-dependent dilation have been limited to relatively small and selected samples and yielded conflicting results. For example, Fichtlscherer and colleagues 8 reported that CRP correlated with endothelial dysfunction in forearm microvessels in coronary disease patients and that time-dependent improvements in endothelial function paralleled reductions in CRP. Several groups also reported a significant correlation between CRP and lower brachial artery flow-mediated dilation. 20,21 In the coronary circulation, CRP levels correlated with more severe constrictor responses to the cold pressor test, which may reflect, in part, endothelial dysfunction. 22 In contrast, CRP did not correlate with coronary endothelial dysfunction (assessed by acetylcholine infusion) in patients with coronary
4 Vita et al Inflammation and Endothelial Function 3607 TABLE 4. Relations Between Measures of Vascular Function and Markers of Inflammation Spearman Partial Correlation Coefficient (P) Parameter and Model CRP IL-6 sicam-1 MCP-1 Flow-mediated dilation, mm (n 2701) Raw (0.0004) ( ) ( ) (0.08) Age-gender (0.047) (0.007) (0.015) (0.36) Multivariable* (0.67) (0.35) (0.19) (0.16) Flow-mediated dilation, % (n 2701) Raw (0.0004) ( ) ( ) (0.025) Age-gender (0.011) (0.0008) (0.006) (0.45) Multivariable* (0.78) (0.31) (0.17) (0.14) Baseline mean flow (n 1903) Raw ( ) (0.005) (0.003) (0.36) Age-gender ( ) ( ) ( ) (0.0085) Multivariable* (0.05) (0.24) (0.12) (0.31) Hyperemic mean flow (n 1903) Raw ( ) ( ) ( ) ( ) Age-gender (0.0002) (0.0001) (0.02) (0.86) Multivariable* (0.02) (0.01) (0.02) (0.71) Hyperemic-baseline mean flow ratio (n 1903) Raw ( ) ( ) ( ) (0.0002) Age-gender ( ) ( ) ( ) (0.03) Multivariable* (0.0003) (0.003) (0.003) (0.56) *Multivariable partial correlations included age, gender, body mass index, smoking within 6 hours, diabetes mellitus, systolic blood pressure, total cholesterol/hdl cholesterol, heart rate, walk test, lipid therapy, and hormone replacement therapy. artery disease and risk factors. 9 Moreover, CRP did not correlate with brachial artery flow-mediated dilation in patients with familial hypercholesterolemia, 23 Conflicting results have also been reported with regard to the relation between endothelial function and sicam The present study may provide a basis for reconciling this conflicting literature. The previous studies had limited statistical power to adjust for risk factors, whereas the present study had a sample size 10-fold larger than any prior report. We found that adjustment for standard cardiovascular disease risk factors markedly weakened the relation between inflammation and vascular function, which suggests that these risk factors may be the primary driving force for vascular dysfunction, particularly in conduit arteries. Our findings for reactive hyperemia may be of particular interest, however, because adjustment for risk factors did not completely abrogate the relation between inflammatory markers and microvascular function. This finding raises the possibility that some component of inflammation or a source of inflammation in addition to traditional risk factors might contribute to microvascular dysfunction. Overall, these findings support the possibility that systemic inflammation may represent a mechanistic link between risk factors and vascular dysfunction. Flow-mediated dilation represents an important homeostatic response to short-term changes in shear stress at the endothelial surface and depends on production of nitric oxide, Unadjusted and partial correlations between CRP and vascular function. Displayed are unadjusted and partial Spearman correlations for CRP with flowmediated dilation (FMD; left) and CRP with hyperemic flow (right). As shown, correlations were markedly attenuated when we accounted for age and gender and for individual and multiple risk factors as described in Results. DM indicates diabetes mellitus; BMI, body mass index.
5 3608 Circulation December 7, 2004 prostacyclin, and other vasodilators by the endothelium. 17 Inflammation has the potential to impair flow-mediated dilation by reducing the bioavailability of endotheliumderived vasodilators. For example, experimental studies have shown that CRP decreases expression of endothelial nitric oxide synthase (enos) and nitric oxide synthesis, in part by decreasing the half-life of enos message. 5 These effects of CRP might also account for the relation between IL-6 and flow-mediated dilation, because IL-6 is an important stimulus for CRP production in the liver. 3 The strong correlation between CRP and IL-6 observed in the present study is consistent with this possibility (Table 3); however, we cannot exclude the possibility that CRP, IL-6, and sicam-1 are merely markers for the presence of other factors that account mechanistically for the observed variation in vascular function. Reactive hyperemia is a complex response that reflects dilation of microvessels by non endothelium-dependent vasodilators generated during local ischemia, including adenosine. 17 In addition, there is growing recognition that endothelium-derived nitric oxide contributes to reactive hyperemia, as evidenced by reductions in both the peak and overall flow response (area under the curve) during concomitant infusion of enos inhibitors Risk factors and atherosclerosis are associated with a reduced peak hyperemic response, 13 particularly with a loss of the nitric oxide dependent portion of the response. 26,29 Thus, the observed relation between markers of inflammation and lower reactive hyperemia might reflect endothelial dysfunction in the microvasculature. Alternatively, the findings could be attributable to other aspects of vascular dysfunction, including reduced production of non endothelium-dependent dilators, altered function of vascular smooth muscle, or structural changes in the microvasculature that limit dilation. 30,31 Further studies would be needed to investigate these possibilities. Reactive hyperemia and flow-mediated dilation are interrelated. Reactive hyperemia is the stimulus for flow-mediated dilation of the conduit artery. Conversely, flow-mediated dilation of microvessels augments the hyperemic response. The correlation coefficients relating inflammation to hyperemic flow were 2 to 3 times higher than the corresponding correlation coefficients for flow-mediated dilation. We recently observed an inverse correlation between hyperemic flow and traditional risk factors, which provides evidence that risk factors may impair flow-mediated dilation in part by reducing the stimulus for dilation. 13 It is possible that inflammation has a predominant effect on the microvasculature rather than the conduit artery in the forearm. The extent to which this impairment of microvascular function reflects endothelial dysfunction rather than vascular dysfunction remains unknown. We observed only very modest unadjusted correlations between MCP-1 and flow-mediated dilation, and the relations with reactive hyperemia did not persist after adjustment for risk factors. Experimental studies suggest an inhibitory effect of nitric oxide on MCP-1 expression, 32 and many of the same stimuli that promote MCP-1 expression by vascular cells are also associated with decreased bioavailability of nitric oxide. 33 Thus, it is unclear why a stronger relation was not observed. It is possible that serum levels of MCP-1 do not reflect the local vascular wall milieu to the same extent that the soluble form of ICAM-1 reflects expression at the luminal surface of the endothelium. The present study has several limitations. We emphasize that this cross-sectional study cannot establish mechanistic links between risk factors, systemic inflammation, and vascular function, although our results are consistent with this possibility. The findings could be explained by novel risk factors or genetic polymorphisms that were not included in our models. It also remains possible, although unlikely, that inflammation and vascular dysfunction are entirely distinct phenomena produced separately by risk factors. In addition, our cohort was predominantly white, and our finding may not apply to other ethnic/racial groups. Finally, flow-mediated dilation was relatively low compared with some prior studies, which likely reflects the older age of the participants and the below-elbow cuff position, 34 although results of the present study are similar to those of prior studies that used the same cuff position and comparable subjects. 35,36 It remains possible that a very modest correlation between flow-mediated dilation and markers of inflammation was undetected. In spite of these limitations, the present study has several strengths, which include a community-based cohort, which enhances generalizability, and the large sample size, which provides excellent power and the ability to adjust for multiple routinely ascertained covariates. In conclusion, traditional cardiovascular disease risk factors appear to account for much of the relation between serum markers of inflammation and 2 aspects of vascular function, specifically brachial artery flow-mediated dilation and reactive hyperemia, in this community-based cohort. These observations are consistent with the hypothesis that traditional risk factors induce a state of inflammation that impairs endothelial and/or vascular function in the forearm. Our findings may have clinical relevance, because endothelial dysfunction is strongly linked to the pathogenesis and clinical expression of atherosclerosis. 4,6 Recent studies suggest that traditional risk factors are the primary driving force for cardiovascular risk, 37,38 and the present study may be consistent with those observations. Longitudinal studies in this and other cohorts may provide additional information about the links between systemic inflammation, vascular dysfunction, and cardiovascular disease. Acknowledgments The study was supported by NIH/NHLBI contract N01-HC and NIH grants HL60040 (Dr Benjamin), HL70100 (Dr Benjamin), HL64753 (Dr Benjamin), DK55656 (Dr Keaney), HL60886 (Drs Vita and Keaney), and K24-HL04334 (Dr Vasan). References 1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105: Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:
6 Vita et al Inflammation and Endothelial Function Widlansky ME, Gokce N, Keaney JF Jr, et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42: Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106: Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation. 2002;106: Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102: Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102: Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106: Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110: Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of endothelial function in the community: the Framingham Heart Study. Circulation. 2004;109: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 34. Bethesda, Md: National Heart, Lung, and Blood Institute; NIH publication No Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension. 2004;44: Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23: Keaney JF Jr, Massaro JM, Larson MG, et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol. 2004;44: SAS Institute Inc. SAS Procedures Guide, Version 8. Cary, NC: SAS Institute; Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39: Gimbrone MA Jr, Topper JN, Nagel T, et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000;902: Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349: Tan KC, Chow WS, Tam SC, et al. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2002;87: Brevetti G, Silvestro A, Di Giacomo S, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38: Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation. 2001;104: van Haelst PL, van Doormaal JJ, Asselbergs FW, et al. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond). 2003;104: Witte DR, Broekmans WM, Kardinaal AF, et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis. 2003;170: John S, Jacobi J, Delles C, et al. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin Sci (Lond). 2000;98: Dakak N, Husain S, Mulcahy D, et al. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction and effect of L-arginine. Hypertension. 1998;32: Tagawa T, Imaizumi T, Endo T, et al. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90: Meredith IT, Currie KE, Anderson TJ, et al. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435 H Higashi Y, Sasaki S, Nakagawa K, et al. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001;87: Christensen KL. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension. 1991;18: Moreau P, d Uscio LV, Luscher TF. Structure and reactivity of small arteries in aging. Cardiovasc Res. 1998;37: Tsao PS, Wang B, Buitrago R, et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997;96: Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol. 1998;9: Mannion TC, Vita JA, Keaney JF Jr, et al. Non-invasive assessment of brachial artery endothelial vasomotor function is associated with a low level of discomfort. Vasc Med. 1998;3: Herrington DM, Espeland MA, Crouse JR III, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol. 2001;21: Liu PY, Wishart SM, Celermajer DS, et al. Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. Eur J Endocrinol. 2003;148: Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290: Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:
The Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationThe 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories
The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury
More informationAcute Effects of Vasoactive Drug Treatment on Brachial Artery Reactivity
Journal of the American College of Cardiology Vol. 40, No. 4, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02034-X
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationHow to detect early atherosclerosis ; focusing on techniques
How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationA study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20171037 A study of brachial
More informationThe initial description in 1980 by Furchgott and
MINI-REVIEW: EXPERT OPINIONS Testing Endothelial Vasomotor Function Nitric Oxide, a Multipotent Molecule Peter Ganz, MD; Joseph A. Vita, MD The initial description in 1980 by Furchgott and Zawadzki 1 of
More informationReceived: March 2008; in final form May 2008.
RELATIONSHIP BETWEEN BRACHIAL ARTERY FLOW- MEDIATED DILATION AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN THE MIDDLE-AGED SUBJECTS WITH LOW CARDIOVASCULAR RISK GERMAINE SĂVOIU*, LAVINIA NOVEANU**, O. FIRA-MLADINESCU*,
More informationThe Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research
The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex
More informationConduit Artery Constriction Mediated by Low Flow
Journal of the American College of Cardiology Vol. 51, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.01.049
More informationBrachial artery hyperemic blood flow velocities are related to carotid atherosclerosis Susann J. Järhult, Johan Sundström and Lars Lind
Clin Physiol Funct Imaging (29) doi: 1.1111/j.1475-97X.29.879.x Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis Susann J. Järhult, Johan Sundström and Lars Lind Department
More informationThe Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 1 Number 1 The Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects L Zhu, K Liu Citation L Zhu, K
More informationATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.
Hyperglycemia and Coronary Events: where is the link? ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG. Cardiovascular (CV) disease is the primary complication of diabetes ~65% of deaths are due to CV disease Coronary
More informationEndothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors
Original Article Endothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors Mani Prasad Gautam, 1 Samir Gautam, 2 Usha Ghimire, 3 Sogunuru Guruprasad, 4
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationRisk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function. A Prospective Study
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function A Prospective Study Noyan Gokce, MD; John F. Keaney, Jr, MD; Liza M. Hunter, ANP; Michael
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationAN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE
AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE Good for your patients. Good for your practice. Using the AngioDefender system to complement your patients care routine enables you to: Improve your patient
More informationInflammation plays a major role in atherosclerosis, 1 and
Soluble P-Selectin and the Risk of Future Cardiovascular Events Paul M. Ridker, MD; Julie E. Buring, ScD; Nader Rifai, PhD Background P-selectin, a cell-surface adhesion molecule involved in leukocyte
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationRelationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases
Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and
More informationNovel Markers of Arterial Dysfunction
혈관연구회창립심포지움, 3 월 3 일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea Atherosclerosis: A progressive process PHASE I: Initiation
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationLa Trombosi Arteriosa
La Trombosi Arteriosa Prof. Giovanni Davì Medicina Interna Chieti Platelet activation and thrombosis Harrison 19 edizione Platelets are essential for primary hemostasis and repair of the endothelium They
More informationC-reactive protein: a marker or a player?
C-reactive protein: a marker or a player? Thomas Nyström, Thomas Nyström To cite this version: Thomas Nyström, Thomas Nyström. C-reactive protein: a marker or a player?. Clinical Science, Portland Press,
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More information10/17/16. Assessing cardiovascular risk through use of inflammation testing
Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response
More informationAngioDefender. A man is as old as his arteries. Dr. Thomas Sydenham, British physician ( ) known as the English Hippocrates
AngioDefender A man is as old as his arteries Dr. Thomas Sydenham, British physician (1624-1689) known as the English Hippocrates Since the dawn of modern clinical medicine, when patient observation and
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationThe Relationships of Cardiovascular Disease Risk Factors to Flow-Mediated Dilatation in Japanese Subjects Free of Cardiovascular Disease
2019 Original Article Hypertens Res Vol.31 (2008) No.11 p.2019-2025 The Relationships of Cardiovascular Disease Risk Factors to Flow-Mediated Dilatation in Japanese Subjects Free of Cardiovascular Disease
More informationClassification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More informationDyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram
Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III
More informationThe JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009
The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationLifetime Risk of Cardiovascular Disease Among Individuals with and without Diabetes Stratified by Obesity Status in The Framingham Heart Study
Diabetes Care Publish Ahead of Print, published online May 5, 2008 Lifetime Risk of Cardiovascular Disease Among Individuals with and without Diabetes Stratified by Obesity Status in The Framingham Heart
More informationThe endothelium controls vascular tone, coagulation, and
Preventive Cardiology Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults The Cardiovascular Risk in Young Finns Study Markus Juonala, MD; Jorma S.A.
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationPrognostic Value of Brachial Artery Endothelial Function and Wall Thickness
Journal of the American College of Cardiology Vol. 46, No. 6, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.070
More informationThe Role of Unknown Risk Factors in Myocardial Infarction
Elmer Press Original Article The Role of Unknown Risk Factors in Myocardial Infarction Rafighdoust Abbas Ali a, d, Mirzaee Asadollah b, Rafigdoust Amir Hossien c Abstract Background: Atherosclerosis of
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationPut your Heart before your Head
Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."
More informationIndependent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension
(2005) 19, 149 154 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Independent association between inflammatory markers (C-reactive protein, interleukin-6,
More informationOriginal Article Seasonal variation of endothelium-dependent flowmediated vasodilation measured in the same subjects
Am J Cardiovasc Dis 2012;2(2):111-115 www.ajcd.us /ISSN:2160-200X/AJCD1203001 Original Article Seasonal variation of endothelium-dependent flowmediated vasodilation measured in the same subjects Masako
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationAmlodipine/atorvastatin has an effect on vascular function and normal lipid levels.
Biomedical Research 2017; 28 (9): 3821-3825 ISSN 0970-938X www.biomedres.info Amlodipine/atorvastatin has an effect on vascular function and normal lipid levels. Zhao Xin-ke 1, Feng Ming-xia 2, Qiao Ai-ling
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationImpact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function. Sex-Related Differences in the Framingham Heart Study
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function Sex-Related Differences in the Framingham Heart Study Martin K. Rutter, MB, ChB; Helen Parise, ScD; Emelia J. Benjamin,
More informationAnnals of RSCB Vol. XIV, Issue 1
THE ROLE OF URIC ACID AS A RISK FACTOR FOR ARTERIAL HYPERTENSION Corina Şerban 1, Germaine Săvoiu 2, Lelia Şuşan 3, Alina Păcurari 3, A. Caraba 3, Anca Tudor 4, Daniela Ionescu 5, I. Romosan 3, A. Cristescu
More informationMitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
DOI 10.1186/s12933-016-0372-y Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationVarious Indices of Arterial Stiffness: Are They Closely Related or Distinctly Different?
Received: October 19, 2016 Accepted after revision: February 8, 2017 Published online: April 7, 2017 Mini-Review Various Indices of Arterial Stiffness: Are They Closely Related or Distinctly Hirofumi Tanaka
More informationHeart Online First, published on March 29, 2005 as /hrt SCIENTIFIC LETTER
Heart Online First, published on March 29, 2005 as 10.1136/hrt.2004.056523 Manuscript ID: HEARTJNL/2004/056523 March 18, 2005 SCIENTIFIC LETTER Effects of HMG-CoA Reductase Inhibition on Endothelial Function
More informationCardiovascular Division, Brigham and Women s Hospital, Harvard Medical School
Low Endothelial Shear Stress Upregulates Atherogenic and Inflammatory Genes Extremely Early in the Natural History of Coronary Artery Disease in Diabetic Hyperlipidemic Juvenile Swine Michail I. Papafaklis,
More informationThe Clinical Implications of Endothelial Dysfunction
Journal of the American College of Cardiology Vol. 42, No. 7, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00994-x
More informationEpidemiological studies indicate that a parental or family
Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women Howard D. Sesso, ScD, MPH; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD, MPH; Kathryn M. Rexrode,
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationEndothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome
Med Sci Monit, 2011; 17(2): 73-77 PMID: 21278691 WWW.MEDSCIMONIT.COM Clinical Research Received: 2010.05.10 Accepted: 2010.08.09 Published: 2011.02.01 Endothelial function and left ventricular remodeling
More informationJournal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00680-X Lack
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 N OVEMBER 1, 2001 NUMBER 18 IMPACT OF HIGH-NORMAL BLOOD PRESSURE ON THE RISK OF CARDIOVASCULAR DISEASE
More informationInflammation as A Target for Therapy. Focus on Residual Inflammatory Risk
ESC Rome Monday August 29, 2016 Inflammation as A Target for Therapy Focus on Residual Inflammatory Risk Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center
More informationMaria Angela S. Cruz-Anacleto, MD
Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort
More informationHypertension is a central risk factor for cardiovascular
Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events Gavin J. Blake, MD, MPH, MRCPI; Nader Rifai, PhD; Julie E. Buring, ScD; Paul M Ridker, MD, MPH Background Accumulating data
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationRisks and benefits of weight loss: challenges to obesity research
European Heart Journal Supplements (2005) 7 (Supplement L), L27 L31 doi:10.1093/eurheartj/sui083 Risks and benefits of weight loss: challenges to obesity research Donna Ryan* Pennington Biomedical Research
More informationInvited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases
Histol Histopathol (2000) 15: 557-571 Histology and Histopathology Cellular and Molecular Biology Invited Review Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular
More informationSystemic Inflammation and COPD*
CHEST Systemic Inflammation and COPD* The Framingham Heart Study Original Research Robert E. Walter, MD, MPH; Jemma B. Wilk, DSc; Martin G. Larson, ScD; Ramachandran S. Vasan, MD; John F. Keaney, Jr, MD;
More informationAllopurinol and Nitric Oxide Activity in the Cerebral Circulation of those with Diabetes; a Randomised Trial
Diabetes Care Publish Ahead of Print, published online October 22, 2008 Allopurinol and Nitric Oxide Activity in the Cerebral Circulation of those with Diabetes; a Randomised Trial 1 Jesse Dawson MRCP,
More informationBrachial artery hyperaemic blood flow velocity and left ventricular geometry
(2011), 1 5 & 2011 Macmillan Publishers Limited All rights reserved 0950-9240/11 www.nature.com/jhh ORIGINAL ARTICLE Brachial artery hyperaemic blood flow velocity and left ventricular geometry SJ Järhult,
More informationMicrovascular Disease: How to Diagnose and What s its Treatment
Microvascular Disease: How to Diagnose and What s its Treatment Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/28524 holds various files of this Leiden University dissertation Author: Djaberi, Roxana Title: Cardiovascular risk assessment in diabetes Issue Date: 2014-09-04
More informationRetinal vessel analysis in dyslipidemia: The eye, a window to the body s microcirculation
Project Summary SWISS LIPID RESEARCH AWARD 2017 SPONSORED BY AMGEN Retinal vessel analysis in dyslipidemia: The eye, a window to the body s microcirculation Matthias P. Nägele, M.D. 1, Jens Barthelmes,
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationHigh Density Lipoprotein Cholesterol and Mortality
High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants
More informationPulse wave velocity, augmentation index and arterial age in students
Pulse wave velocity, augmentation index and arterial age in students IOANA MOZOS 1, SERBAN GLIGOR 2 1 Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara ROMANIA
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationOverview of effects of alcohol intake on cardiovascular disease
Beverage specific effects Overview of effects of alcohol intake on cardiovascular disease Dr. Ramon Estruch Department of Internal Medicine, Barcelona University, Spain. CIBER OBN Institute of Health Carlos
More informationClinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community. The Framingham Heart Study
Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community The Framingham Heart Study Ali Morshedi-Meibodi, MD; Jane C. Evans, DSc; Daniel Levy, MD;
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationWomen and Coronary Artery Disease:
Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist
More informationAgrowing body of data indicates that plaque inflammation
Unstable Angina and Elevated C-Reactive Protein Levels Predict Enhanced Vasoreactivity of the Culprit Lesion Fabrizio Tomai, MD; Filippo Crea, MD; Achille Gaspardone, MD; Francesco Versaci, MD; Anna S.
More informationRelationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers
J Cardiol 2001 ; 38: 21 28 Relationship Between Endothelial Dysfunction and Nitric Oxide Production in Young Male Smokers Tomoyuki Taku Takaharu Kotaro Sachie Minoru Shunsuke Iwao Kazuyuki Katsuharu Tohru
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More information